Rankings
▼
Calendar
INMB Q3 2016 Earnings — INmune Bio, Inc. Revenue & Financial Results | Market Cap Arena
INMB
INmune Bio, Inc.
$38M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$54,197
Net Income
-$54,197
EPS (Diluted)
$-0.01
Cash Flow
Operating Cash Flow
$0
Free Cash Flow
$0
Stock-Based Comp.
$0
← FY 2016
All Quarters
Q4 2016 →
